BURLINGAME, Calif. (AP) _ Corvus Pharmaceuticals Inc. (CRVS) on Monday reported a loss of $10.7 million in its third quarter.

On a per-share basis, the Burlingame, California-based company said it had a loss of 24 cents.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRVS at https://www.zacks.com/ap/CRVS

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News